| 6033 |
Extreme Co., Ltd.
|
Other |
|
Notice Regarding the Opening of Fukuoka Office
|
Aug 14, 2026
|
| 6033 |
extreme Co., Ltd.
|
Other |
|
Matters Concerning Business Plan and Growth Potential
|
Aug 14, 2026
|
| 6033 |
Extreme
|
Other |
|
Presentation of Medium-Term Management Plan / Business Strategy and Disclosure of Management Challenges
|
Aug 14, 2026
|
| 3417 |
Oki HealthCare Holdings Co., Ltd.
|
Other |
|
Notice of Changes in Major Shareholders
|
Aug 14, 2026
|
| 8570 |
AEON Financial Services Co., Ltd.
|
Other |
|
Notice Regarding Changes in Major Shareholders
|
Aug 13, 2026
|
| 8952 |
Japan Real Estate Investment Corporation
|
Other |
|
Notice Regarding Early Repayment of Borrowed Funds
|
Aug 13, 2026
|
| 5845 |
Zenbo Ren Co., Ltd.
|
Other |
|
Notice regarding the relocation of head office
|
Aug 13, 2026
|
| 7063 |
Birdman Co., Ltd.
|
Other |
|
GAKUSEI RUNWAY 2026 WINTER in YOKOHAMA Announcement of Venue and Schedule
|
Aug 13, 2026
|
| 8518 |
日 本 ア ジ ア 投 資 株 式 会 社
|
Other |
|
日 本 ア ジ ア 投 資 株 式 会 社 重要株主の異動のお知らせ
|
Aug 12, 2026
|
| 9514 |
EFON
|
Other |
|
Notice on the Board of Directors’ Opinion regarding shareholder proposals
|
Aug 12, 2026
|
| 6291 |
日本エアーテック株式会社
|
Other |
|
Efforts toward realizing management conscious of capital cost and share price
|
Aug 12, 2026
|
| 4391 |
Logizard Co., Ltd.
|
Other |
|
Presentation Material (IR Materials)
|
Aug 12, 2026
|
| 3359 |
Kot ta? Wait: 株式会社cotta
|
Other |
|
2026 Fiscal Year September Quarter 3 Interim Performance Summary and Other Supplementary Materials
|
Aug 12, 2026
|
| 4071 |
Plus Alpha Consulting Co., Ltd.
|
Other |
|
Notice Regarding Head Office Relocation
|
Aug 12, 2026
|
| 9633 |
Tokyo Theatres Co., Ltd.
|
Other |
|
Notice of Changes (Expansion) to the Shareholder Benefit Program
|
Aug 12, 2026
|
| 4415 |
Broad Enterprise
|
Other |
|
Notice regarding the securitization of receivables
|
Aug 12, 2026
|
| 4506 |
Sumitomo Pharma Co., Ltd.
|
Other |
|
View on Our Report (Response to Gotham City Research LLC’s August 7, 2026 Report)
|
Aug 12, 2026
|
| 4005 |
Sumitomo Pharma Co., Ltd.
|
Other |
|
About this report (Sumitomo Chemical and Sumitomo Pharmaceutical: Part II – CiRA, Dr. Yamanaka, and the undisclosed history of image-duplication concerns)
|
Aug 12, 2026
|
| 4889 |
Renascience Inc.
|
Other |
|
Notice Regarding Withdrawal from XPRIZE Healthspan
|
Aug 11, 2026
|
| 6071 |
IBJ Inc.
|
Other |
|
Notice of Continued Selection as a Constituent of the JPX-Nikkei Small Cap Index
|
Aug 10, 2026
|
